Search
for
Sort by
Research 31–60 of 56
- Fertility evaluation of infertile women: a committee opinion
- Short‐Term, Low‐Dose Spironolactone for Treatment of Hyperandrogenic Symptoms of Polycystic Ovary Syndrome—A Systematic Review
- Hormonal Therapies for Acne: A Comprehensive Update for Dermatologists
- Assessing medication use patterns among patients with polycystic ovary syndrome at a tertiary care teaching hospital in South Korea: A retrospective study
- Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing
- Effects of Low-Dose Spironolactone Combined with Metformin or Either Drug Alone on Insulin Resistance in Patients with Polycystic Ovary Syndrome: A Pilot Study
- Bariatric surgery for spontaneous ovulation in women living with polycystic ovary syndrome: the BAMBINI multicentre, open-label, randomised controlled trial
- A clinico-pathological study of Neogynon as a new oral contraceptive steroid.
- [Favorable effects of estrogens and progesterones on general diseases].
- Kisspeptin and LH pulsatile temporal coupling in PCOS patients
- Patterns of ovarian morphology in polycystic ovary syndrome: a study utilising magnetic resonance imaging
- Genetic basis of polycystic ovary syndrome
- American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1
- Ovarian Morphology Is a Marker of Heritable Biochemical Traits in Sisters with Polycystic Ovaries
- Serum Levels of Retinol-Binding Protein 4 and Adiponectin in Women with Polycystic Ovary Syndrome: Associations with Visceral Fat But No Evidence for Fat Mass-Independent Effects on Pathogenesis in This Condition
- Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial
- Is 3α, 17β-androstanediol-glucuronide a diagnostic marker in women with androgenic manifestations?
- Ghrelin levels are suppressed and show a blunted response to oral glucose in women with polycystic ovary syndrome.
- Polycystic Ovarian Syndrome: Long-Term Health Consequences
- Normal Pubertal Development in Daughters of Women With PCOS: A Controlled Study
- Prevalence, Phenotypes, and Comorbidities of Polycystic Ovary Syndrome Among Indian Women
- Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS
- Toxicity of repeated oral intake of organic selenium, inorganic selenium, and selenium nanoparticles: A review
- Comparative advantage and efficacy of natural products for polycystic ovary syndrome
- Impact of Reducing Obesity in PCOS: Methods and Treatment Outcomes
- The role of high serum uric acid levels in androgenic and non-androgenic polycystic ovarian syndrome patients
- (13) Tolerance of spironolactone
- Comparison of spironolactone and spironolactone plus metformin in the treatment of polycystic ovary syndrome
- Side-effects and possible complications of oral contraceptive drugs.
- Venous thromboembolism and women's health